4.7 Article

Neurological signs in relation to type of cerebrovascular disease in vascular dementia

期刊

STROKE
卷 39, 期 2, 页码 317-322

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.107.493353

关键词

MRI; neurological signs; vascular dementia

向作者/读者索取更多资源

Background and Purpose-The aim of this study was to describe the prevalence of a number of neurological signs in a large population of patients with vascular dementia (VaD) and to compare the relative frequency of specific neurological signs dependent on type of cerebrovascular disease. Methods-Seven hundred six patients with VaD (NINDS-AIREN) were included from a large multicenter clinical trial (registration number NCT00099216). At baseline neurological examination, the presence of 16 neurological signs was assessed. Based on MRI, patients were classified as having large vessel VaD (18%; large territorial or strategical infarcts on MRI), small vessel VaD (74%; white matter hyperintensities [WMH], multiple lacunes, bilateral thalamic lesions on MRI), or a combination of both (8%). Results-A median number of 4.5 signs per patient was presented (maximum 16). Reflex asymmetry was the most prevalent symptom (49%), hemianopia was most seldom presented (10%). Measures of small vessel disease were associated with an increased prevalence of dysarthria, dysphagia, parkinsonian gait disorder, rigidity, and hypokinesia and as well to hemimotor dysfunction. By contrast, in the presence of a cerebral infarct, aphasia, hemianopia, hemimotor dysfunction, hemisensory dysfunction, reflex asymmetry, and hemiplegic gait disorder were more often observed. Conclusions-The specific neurological signs demonstrated by patients with VaD differ according to type of imaged cerebrovascular disease. Even in people who meet restrictive VaD criteria, small vessel disease is often seen with more subtle signs, including extrapyramidal signs, whereas large vessel disease is more often related to lateralized sensorimotor changes and aphasia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis

Floor C. Loonstra, Lodewijk R. J. de Ruiter, Marleen J. A. Koel-Simmelink, Menno M. Schoonheim, Eva M. M. Strijbis, Bastiaan Moraal, Frederik Barkhof, Bernard M. J. Uitdehaag, Charlotte Teunissen, Joep Killestein

Summary: This study explores the association between novel blood biomarkers (sNfL, sGFAP, and sCNTN1) and disability outcome measures and MRI volumes in people with multiple sclerosis (MS). The results indicate that sNfL and sGFAP are associated with disease progression, while sCNTN1 is not related to clinical or MRI measures.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Article Clinical Neurology

Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets A MAGNIFY-MS Substudy

Heinz Wiendl, Klaus Schmierer, Suzanne Hodgkinson, Tobias Derfuss, Andrew Chan, Finn Sellebjerg, Anat Achiron, Xavier Montalban, Alexandre Prat, Nicola De Stefano, Frederik Barkhof, Letizia Leocani, Patrick Vermersch, Anita Chudecka, Claire Mwape, Kristina H. Holmberg, Ursula Boschert, Sanjeev Roy, MAGNIFY-MS Study Grp

Summary: Cladribine tablets cause a reduction in lymphocytes, with a predominant effect on B-cell and T-cell counts. The MAGNIFY-MS substudy reports the dynamic changes on multiple peripheral blood mononuclear cell (PBMC) subtypes and immunoglobulin (Ig) levels over 12 months after the first course of cladribine tablets in patients with highly active relapsing multiple sclerosis (MS).

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Article Neurosciences

MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies

Anna Inguanzo, Konstantinos Poulakis, Rosaleena Mohanty, Christopher G. Schwarz, Scott A. Przybelski, Patricia Diaz-Galvan, Val J. Lowe, Bradley F. Boeve, Afina W. Lemstra, Marleen van de Beek, Wiesje van der Flier, Frederik Barkhof, Frederic Blanc, Paulo Loureiro de Sousa, Nathalie Philippi, Benjamin Cretin, Catherine Demuynck, Zuzana Nedelska, Jakub Hort, Barbara Segura, Carme Junque, Ketil Oppedal, Dag Aarsland, Eric Westman, Kejal Kantarci, Daniel Ferreira

Summary: Using MRI data, we identified three subtypes of Dementia with Lewy bodies (DLB): older subtype with reduced cortical GM volumes and worse cognition, subtype with low GM volumes in fronto-occipital regions, and a younger subtype with the highest cortical GM volumes, lower GM volumes in basal ganglia, and cognitive fluctuations. These subtypes have implications for clinical practice, research, and treatment decisions.

NPJ PARKINSONS DISEASE (2023)

Article Clinical Neurology

Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab

C. Mallinckrodt, Y. Tian, P. S. Aisen, F. Barkhof, S. Cohen, G. Dent, O. Hansson, K. Harrison, T. Iwatsubo, C. J. Mummery, K. K. Muralidharan, I. Nestorov, L. Nisenbaum, R. Rajagovindan, C. von Hehn, C. H. van Dyck, B. Vellas, S. Wu, Y. Zhu, A. Sandrock, T. Chen, S. Budd Haeberlein

Summary: Post-hoc analyses of the EMERGE and ENGAGE studies showed that the outcomes in the high-dose group of ENGAGE were affected by an imbalance in a small number of rapidly progressing patients and lower exposure to the target dose. However, these factors were only present in early enrolled patients and did not affect later enrolled patients. Baseline characteristics and amyloid-related imaging abnormalities did not contribute to the difference in results between the high-dose arms.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2023)

Article Geriatrics & Gerontology

Determinants of quality of life in family caregivers in MCI: a comparison with mild dementia

Eva Y. L. Tan, Niels Janssen, Ron Handels, Inez H. G. B. Ramakers, Frans R. J. Verhey, Wiesje M. van der Flier, Rene J. F. Melis, Marcel G. M. Olde Rikkert, Jos M. G. A. Schols, Marjolein E. de Vugt

Summary: The objective of this study was to investigate the health-related quality of life (HRQol) of family caregivers of individuals with mild cognitive impairment (MCI), and to explore possible determinants and differences compared to caregivers of individuals with mild dementia. The study found no significant difference in HRQoL between family caregivers of individuals with MCI and mild dementia. However, caregiver characteristics, such as being a spouse and having a lower educational level, were associated with lower HRQoL.

AGING & MENTAL HEALTH (2023)

Article Clinical Neurology

Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease

Liu Shi, Jin Xu, Rebecca Green, Asger Wretlind, Jan Homann, Noel J. Buckley, Betty M. Tijms, Stephanie J. B. Vos, Christina M. Lill, Mara ten Kate, Sebastiaan Engelborghs, Kristel Sleegers, Giovanni B. Frisoni, Anders Wallin, Alberto Lleo, Julius Popp, Pablo Martinez-Lage, Johannes Streffer, Frederik Barkhof, Henrik Zetterberg, Pieter Jelle Visser, Simon Lovestone, Lars Bertram, Alejo J. Nevado-Holgado, Petroula Proitsi, Cristina Legido-Quigley

Summary: This study employed an integrative system and causal inference approach to explore molecular signatures in blood and CSF, the AT(N) framework, MCI conversion to AD, and genetic risk for AD. Using the EMIF-AD cohort, the researchers measured proteins and metabolites in blood and CSF, as well as genotyped whole-blood samples. They found associations between AT(N) framework and protein/lipid hubs, and identified Proprotein Convertase Subtilisin/Kexin Type 7 as a potential causative factor for AD.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Genetically identical twin-pair difference models support the amyloid cascade hypothesis

Emma M. Coomans, Jori Tomassen, Rik Ossenkoppele, Betty M. Tijms, Luigi Lorenzini, Mara ten Kate, Lyduine E. Collij, Fiona Heeman, Roos M. Rikken, Sophie M. van der Landen, Marijke E. den Hollander, Sandeep S. Golla, Maqsood Yaqub, Albert D. Windhorst, Frederik Barkhof, Philip Scheltens, Eco J. C. de Geus, Pieter Jelle Visser, Bart N. M. van Berckel, Anouk den Braber

Summary: The amyloid cascade hypothesis has played a significant role in Alzheimer's disease research and clinical trial designs. This study investigated the relationship between amyloid-beta and tau at the individual and twin-pair levels, aiming to rule out genetic and shared environmental effects as confounders. The findings suggest that the associations between amyloid-beta, tau, neurodegeneration, and cognition are unbiased by genetic factors, and the effects of amyloid-beta on neurodegeneration and cognitive decline are mediated by tau.
Article Clinical Neurology

Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis

Diana I. Bocancea, Anna L. Svenningsson, Anna C. van Loenhoud, Colin Groot, Frederik Barkhof, Olof Strandberg, Ruben Smith, Renaud La Joie, Howard J. Rosen, Michael J. Pontecorvo, Gil D. Rabinovici, Wiesje M. van der Flier, Oskar Hansson, Rik Ossenkoppele

Summary: The mechanisms of resilience against tau pathology in Alzheimer's disease spectrum are not well understood. This longitudinal study investigates the factors that contribute to cognitive and brain resilience against tau pathology and finds that education is the most important determinant of resilience. However, resilience may be depleted in advanced stages of the disease.
Editorial Material Clinical Neurology

Brain Shrinkage in Anti-β-Amyloid Alzheimer Trials Neurodegeneration or Pseudoatrophy?

Frederik Barkhof, David S. Knopman

Summary: One puzzling observation in Alzheimer's disease therapeutic trials is that treatment with anti-amyloid-beta agents does not preserve brain volume. In a recent study, Alves et al. conducted a meta-analysis and found that these agents do not slow the rate of brain volume loss. In fact, depending on the drug class, they can even accelerate loss of whole-brain and hippocampal volume and increase ventricular volume.

NEUROLOGY (2023)

Article Multidisciplinary Sciences

What does heritability of Alzheimer's disease represent?

Emily Baker, Ganna Leonenko, Karl Michael Schmidt, Matthew Hill, Amanda J. Myers, Maryam Shoai, Itziar de Rojas, Niccolo Tesi, Henne Holstege, Wiesje M. van der Flier, Yolande A. L. Pijnenburg, Agustin Ruiz, John Hardy, Sven van der Lee, Valentina Escott-Price

Summary: Late-onset Alzheimer's disease has a strong genetic component, and the heritability estimates range from 38% to 66%. The APOE region and microglial-related genes play important roles in the genetic architecture of the disease.

PLOS ONE (2023)

Article Clinical Neurology

Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis

Alberto Calvi, Zoe Mendelsohn, Weaam Hamed, Declan Chard, Carmen Tur, Jon Stutters, David MacManus, Baris Kanber, Claudia A. M. Gandini Wheeler-Kingshott, Frederik Barkhof, Ferran Prados

Summary: This study retrospectively analyzed a fingolimod trial in patients with primary progressive MS (PPMS) and found that newly appearing lesions are common and can develop into chronic active lesions. Treatment can reduce the number of these lesions.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Editorial Material Clinical Neurology

Treatments for AD: towards the right target at the right time

Wiesje M. van der Flier, Betty M. Tijms

NATURE REVIEWS NEUROLOGY (2023)

Article Neurosciences

Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies

Ariane Bollack, Pawel J. Markiewicz, Alle Meije Wink, Lloyd Prosser, Johan Lilja, Pierrick Bourgeat, Jonathan M. Schott, William Coath, Lyduine E. Collij, Hugh G. Pemberton, Gill Farrar, Frederik Barkhof, David M. Cash

Summary: This study evaluated the performance of four novel data-driven metrics against conventional techniques for quantifying amyloid-beta (Aβ) pathology. The results showed that the Aβ load, Aβ index, and CLNMF metrics can provide comparable performance to established quantification methods. These new metrics may offer more precise alternatives and further studies in larger cohorts should be conducted.

NEUROIMAGE (2023)

Article Clinical Neurology

Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies

Emma M. Coomans, Lotte A. de Koning, Roos M. Rikken, Sander C. J. Verfaillie, Denise Visser, Anouk den Braber, Jori Tomassen, Marleen van de Beek, Lyduine E. Collij, Afina W. Lemstra, Albert D. Windhorst, Frederik Barkhof, Sandeep S. V. Golla, Pieter Jelle Visser, Philip Scheltens, Wiesje M. van der Flier, Rik Ossenkoppele, Bart N. M. van Berckel, Elsmarieke van de Giessen

Summary: This study evaluated the performance of the visual read method in participants along the AD continuum and dementia with Lewy bodies (DLB), showing excellent inter-reader agreement, strong correspondence with semiquantification, and associations with clinically relevant variables. The visual read status remained stable over a two-year follow-up period and was associated with a decline in Mini-Mental State Examination scores, indicating its reliability and prognostic potential. Future studies in unselected cohorts are needed for better generalizability to the clinical population.

NEUROLOGY (2023)

Article Clinical Neurology

Soap bubble sign as an imaging marker for posterior fossa ependymoma Group B

Ying Jin, Dan Cheng, Yunyun Duan, Zhizheng Zhuo, Jinyuan Weng, Chengzhou Zhang, Mingwang Zhu, Xing Liu, Jiang Du, Tiantian Hua, Hongfang Li, Sven Haller, Frederik Barkhof, Yaou Liu

Summary: The purpose of this study was to investigate the predictive value of the soap bubble sign on molecular subtypes of posterior fossa ependymomas (PF-EPNs). The soap bubble sign was observed in PFB cases but not in PFA cases. The findings suggest that the soap bubble sign is a highly specific imaging marker for the PFB molecular subtype of PF-EPNs.

NEURORADIOLOGY (2023)

暂无数据